Deals
Mercuria's third founder: China head eyes long game
The little known Asia head of Mercuria will be key in tying the Swiss commodity trader's $3.5 billion acquisition of JP Morgan Chase and Co's physical commodity desk into the company's China business.
Japan's Daiichi Sankyo to acquire US biopharma Ambit Biosciences
Japanese drugmaker Daiichi Sankyo Co Ltd (4568.T) has agreed to acquire U.S. biopharmaceutical company Ambit Biosciences Corp (AMBI.O) in a deal valued up to $410 million as it looks to build its presence in oncology, the companies said.
Alibaba pays $459 million for stake in Chinese hotel tech company
Alibaba Group Holding Ltd, in its first big investment since raising $25 billion in a record-breaking New York initial public offering, has bought 15 percent of Chinese hospitality technology provider Beijing Shiji Information Technology Co Ltd for 2.81 billion yuan ($458.66 million).
Pimco sees $10 billion in withdrawals after Gross exit: WSJ
Bill Gross's exit from the investment firm Pimco had an immediate impact on the company, with investors withdrawing about $10 billion following the announcement, the Wall Street Journal reported, citing a person familiar with the matter.




